H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

The U.S. Department of Health and Human Services has awarded Moderna (MRNA) $590M to “advance the late-stage development of its mRNA bird flu ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

We recently published a list of These 10 Firms Were Thursday’s Top Performers. In this article, we are going to take a look ...

Investing in under-the-radar stocks can be a savvy move for those ... The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week.

Biotech has lagged even more. The S&P Biotechnology Select Industry Index has returned about 3 per cent annually over 10 ...

Adar Poonawalla, CEO, Serum Institute of India talks to Arijit Barman about a range of issues including the impact of Trump’s ...